drugset / Trial / NCT06443489

A Trial of SHR-4849 in Advanced Solid Tumors

NCT06443489

Phase 1 Recruiting 80 enrolled Suzhou Suncadia Biopharmaceuticals Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

The study is being conducted to evaluate the safety, tolerability and efficacy of SHR-4849 injection in Advanced Solid Tumors. To explore the reasonable dosage of SHR-4849 for Advanced Solid Tumors.

Timeline

Start
2024-06-26
Primary completion
2026-12
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject SHR-4849 Unknown

Indications